Webplus ver – Page 1232 – China Stock Advice

HNP [HUANENG POWER INTERNATIONAL] 6-K: This Form 6-K consists of: (a Sino-foreign joint

[This Form 6-K consists of: (a Sino-foreign joint stock limited company incorporated in the People’s Republic of China) (Stock Code: 902) 2016 Interim Results Announcement Consolidated operating revenue: RMB52.924 billion Net profit attributable to equity holders of the Company: RMB6.177 billion Earnings per share: RMB0.41 INTERIM RESULTS The Board of Directors of Huaneng Power International, Inc. (the “Company”) announces the]

By info| 2016-08-05T02:42:15+00:00 August 4th, 2016|Categories: Chinese Stocks, HNP, Webplus ver|Tags: 0000929058, 2016-08-04, 4911, 6-K, ELECTRIC SERVICES, HNP|0 Comments

OSN [Ossen Innovation] 6-K: Ossen Innovation Announces Formation of Special Committee to

[Ossen Innovation Announces Formation of Special Committee to Evaluate Proposed Transaction SHANGHAI, August 4, 2016 /PRNewswire/ -- Ossen Innovation Co., Ltd. ("Ossen Innovation" or the "Company") (Nasdaq: OSN), a China-based manufacturer of an array of plain surface, rare earth and zinc coated pre-stressed steel materials, today announced that the Company’s Board of Directors, with the unanimous agreement of all directors,] []

By info| 2016-08-05T02:47:59+00:00 August 4th, 2016|Categories: Chinese Stocks, OSN, Webplus ver|Tags: 0001485538, 2016-08-04, 3312, 6-K, OSN, STEEL WORKS, BLAST FURNACES ROLLING MILLS (COKE OVENS)|0 Comments

CNIT [China Information Technology] 6-K: FORM 6-K August 2016 001-35722 CHINA INFORMATION TECHNOLOGY,

[FORM 6-K August 2016 001-35722 CHINA INFORMATION TECHNOLOGY, INC. 21 st Floor, Everbright Bank Building Zhuzilin, Futian District Shenzhen, Guangdong, 518040 Peoples Republic of China Note Note: On July 29, 2016, Mr. Guanguyuan Zong resigned from his position as Chief Marketing Officer of China Information Technology, Inc. (the Company). Mr. Zongs resignation was due to personal reasons and was not]

By info| 2016-08-05T02:50:29+00:00 August 4th, 2016|Categories: Chinese Stocks, CNIT, Webplus ver|Tags: 0001552670, 2016-08-04, 6-K, 7372, CNIT, SERVICES-PREPACKAGED SOFTWARE|0 Comments

CBPO [China Biologic Products] 8-K: FOR RELEASE August 4, 2016 China Biologic Reports

[FOR RELEASE August 4, 2016 China Biologic Reports Financial Results for the Second Quarter of 2016 --2Q16 Total Sales Up 23.4% with Non-GAAP Net Income Up 31.3% YoY in RMB terms, or Up 15.5% YoY to $91.4 Million and 23.1% YoY to $35.2 Million in USD terms, respectively --1H16 Total Sales Up 26.2% with Non-GAAP Net Income Up 30.6% YoY] []

By info| 2016-08-05T02:53:30+00:00 August 4th, 2016|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: 0001369868, 2016-08-04, 2836, 8-K, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

CBPO [China Biologic Products] 10-Q:

[] [STATE OF DELAWARE THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CHINA BIOLOGIC PRODUCTS, INC. Corporation China Biologic Products, Inc., a corporation organized and existing under the laws of the State of Delaware (the “ The name of the Corporation is China Biologic Products, Inc. The original Certificate of Incorporation of the Corporation was filed with the Secretary of State] [Settlement Agreement This settlement agreement (this “Agreement”) was entered into by and among the following parties (the “Parties,” and each a “Party”) in Yunyan District, Guiyang City, China on July 31, 2016: Party A: Guizhou Taibang Biological Products Co., Ltd. Party B: Guiyang Dalin Biologic Technologies Co., Ltd. Party C: Guizhou Jie’an Company Party D: Shenzhen Yigong Shengda Technology Co.,] [Guarantee Agreement This Guarantee Agreement (this “Agreement”) was entered into by the following parties (the “Parties,” and each a “Party”) at No.808 Meeting Room No. 3 Office Building of Guizhou Province Government in Guiyang City, China on July 31, 2016: Party A: Guizhou Taibang Biological Products Co., Ltd. (“Guizhou Taibang”) Party B: Guiyang Dalin Biologic Technologies Co., Ltd. (“Guiyang Dalin”)] [CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (this “Agreement”) is entered into as of this July 1, 2016 (the “Effective Date”) by and between CHINA BIOLOGIC PRODUCTS, INC., a Delaware corporation (the “Company”) and Mr. Hui (David) Li (hereinafter referred to as the “Consultant”). WHEREAS, NOW, THEREFORE, Senior Strategic and Investment Consulting Agreement 1. provided however Term 2. Compensation 3. (c) Consultant] [Second Amended and Restated Employment Agreement Agreement Company Executive This Second Amended and Restated Employment Agreement (this “ 2012 Agreement WHEREAS, the Company and the Executive entered into an employment agreement dated as of May 11, 2012 (the “ 2014 Agreement WHEREAS, the Company and the Executive entered into a renewal employment agreement dated as of May 11, 2014 (the] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th David (Xiaoying) Gao Chief Executive Officer] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Ming Yang (Principal Financial and Accounting Officer) Chief Financial Officer]

By info| 2016-08-05T02:57:50+00:00 August 4th, 2016|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: 0001369868, 10-Q, 2016-08-04, 2836, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

GRO [AGRIA] 6-K: Agria Subsidiary PGG Wrightson Again Raises FY 2016

[Agria Subsidiary PGG Wrightson Again Raises FY 2016 Guidance FY 2016 Operating EBITDA Expected to Exceed Top End of Guidance Range CHRISTCHURCH, NEW ZEALAND -- (Marketwired - August 2, 2016) -- Agria Corporation (NYSE: GRO) (the "Company" or "Agria"), a leading global agriculture company, today announced that its New Zealand-listed subsidiary, PGG Wrightson Limited (NZX: PGW) ("PGW") raised its guidance] []

By info| 2016-08-04T02:55:11+00:00 August 3rd, 2016|Categories: Chinese Stocks, GRO, Webplus ver|Tags: 0001413257, 0100, 2016-08-03, 6-K, AGRICULTURE PRODUCTION - CROPS, GRO|0 Comments

JFC [JPMORGAN CHINA REGION FUND] SC 13G: __________ SCHEDULE 13G (Amendment No. )* JPMorgan China

[__________ SCHEDULE 13G (Amendment No. )* JPMorgan China Region Fund, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 48126T104 (CUSIP Number) August 3, 2016 (Date of Event Which Requires Filing of this Statement) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the]

By info| 2016-08-04T02:58:51+00:00 August 3rd, 2016|Categories: Chinese Stocks, JFC, Webplus ver|Tags: 0000888137, 2016-08-03, JFC, SC_13G|0 Comments

MPEL [Melco Crown Entertainment] 6-K: Change of Non-executive Director MACAU Wednesday, August

[Change of Non-executive Director MACAU Wednesday, August 3, 2016: The Board would like to take this opportunity to express its sincere thanks to Mr. Wang for his valuable contribution to the Company during his tenure of service. The Company also announced that during the Board meeting held today, the Board appointed Mr. Evan Andrew Winkler (Mr. Winkler) to serve] [Form 6K TABLE OF CONTENTS MELCO CROWN ENTERTAINMENT LIMITED Stephanie Cheung Chief Legal Officer and Company Secretary 3]

By info| 2016-08-04T03:01:41+00:00 August 3rd, 2016|Categories: Chinese Stocks, MPEL, Webplus ver|Tags: 0001381640, 2016-08-03, 6-K, 7011, HOTELS and MOTELS, MPEL|0 Comments

NPD [China Nepstar Chain Drugstore] S-8 POS:

[]

By info| 2016-08-04T03:03:48+00:00 August 3rd, 2016|Categories: Chinese Stocks, NPD, Webplus ver|Tags: 0001414850, 2016-08-03, 5912, NPD, RETAIL-DRUG STORES AND PROPRIETARY STORES, S-8_POS|0 Comments

NPD [China Nepstar Chain Drugstore] 6-K: China Nepstar Chain Drugstore Ltd. Announces Completion of

[China Nepstar Chain Drugstore Ltd. Announces Completion of Merger Under the terms of the merger agreement, at the effective time of the merger (the “Effective Time”), each of the Company’s ordinary shares, par value $0.0001 per share (each a “Share” and collectively, the “Shares”), including Shares represented by American Depositary Shares, each representing two Shares (each an “ADS” and collectively,] [FORM 6-K Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. 25F, Neptunus Yinhe Keji Building No.1, Kejizhong 3rd Road, Nanshan District Shenzhen, Guangdong Province 518057 People’s Republic of China x ¨ Form 20-F ¨ x Yes ¨ x Yes Number Description of Document 99.1 Press Release CHINA NEPSTAR CHAIN DRUGSTORE LTD. Zixin Shao Chief Financial Officer]

By info| 2016-08-04T03:06:05+00:00 August 3rd, 2016|Categories: Chinese Stocks, NPD, Webplus ver|Tags: 0001414850, 2016-08-03, 5912, 6-K, NPD, RETAIL-DRUG STORES AND PROPRIETARY STORES|0 Comments